Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector.
By Bailey Lipschultz · Bloomberg
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector.